CS logo
small CS logo
General Hospital Slovenj Gradec

Slovenj Gradec, Slovenia
Hospital in Slovenj Gradec
Gosposvetska cesta 3, 2380 Slovenj Gradec

About General Hospital Slovenj Gradec


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at General Hospital Slovenj Gradec


During the past decade, General Hospital Slovenj Gradec conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "General Hospital Slovenj Gradec" #1 sponsor was "Protalix" with 2 trials, followed by "Shire" with 2 trials sponsored, "Associazione Qol-one" with 1 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored and "University Medical Centre Ljubljana" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at General Hospital Slovenj Gradec


According to Clinical.Site data, the most researched conditions in "General Hospital Slovenj Gradec" are "Fabry Disease" (5 trials), "Critically Ill" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Thrombocytopenia" (1 trials). Many other conditions were trialed in "General Hospital Slovenj Gradec" in a lesser frequency.

Clinical Trials Intervention Types at General Hospital Slovenj Gradec


Most popular intervention types in "General Hospital Slovenj Gradec" are "Biological" (4 trials), "Drug" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "PRX-102 (pegunigalsidase alfa)" (2 trials), "Replagal" (2 trials), "Eltrombopag/Revolade" (1 trials), "Placebo" (1 trials) and "agalsidase beta" (1 trials). Other intervention names were less common.

Clinical Trials Genders at General Hospital Slovenj Gradec


The vast majority of trials in "General Hospital Slovenj Gradec" are 7 trials for "All" genders.

Clinical Trials Status at General Hospital Slovenj Gradec


Currently, there are NaN active trials in "General Hospital Slovenj Gradec". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in General Hospital Slovenj Gradec, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital Slovenj Gradec, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".